Abstract
One in five people have symptoms that persist after 5 weeks, and one in ten have symptoms for 12 weeks or longer after an acute COVID-19 infection ( Office for National Statistics [ONS], 2020 ). NICE ( National Institute for Health and Care Excellence, 2020 ) defines this condition as post-COVID syndrome or long COVID. Common symptoms vary from fatigue, shortness of breath, palpitations, insomnia and anxiety and depression and encompasses a plethora of debilitating symptoms ( Dani et al, 2021 ). The new guideline for NICE (2021) recommends that patients presenting with new or ongoing symptoms 4 weeks or later after an initial COVID infection should have the investigations done to rule out acute, life-threatening complications or identify any unrelated diagnosis ( NICE, 2021 ). Garg et al (2020) suggests that long COVID is a multisystem syndrome and needs a multifaceted approach to tackle the physical, cognitive, psychological, social, and vocational aspects of this condition. This article looks at the literature about long COVID and suggests there is a clear pathway for treatment in primary care. Certainly that all physicians should be equipped to recognise long-COVID and provide supportive management ( Dani et al, 2021 ).
Original language | English |
---|---|
Pages (from-to) | 362-368 |
Number of pages | 7 |
Journal | Journal of Prescribing Practice |
Volume | 3 |
Issue number | 9 |
DOIs | |
Publication status | Published - 02 Sept 2021 |
Keywords
- Pharmacology (medical)
- Pharmacology (nursing)